openPR Logo
Press release

Bacterial Pneumonia Market: Company Profiles, Segments, and Recent Trends Forecast by 2031 | Melinta Therapeutics LLC, Evopoint Biosciences, Aridis Pharmaceuticals Inc

11-15-2024 03:47 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Bacterial Pneumonia Market - DataM Intelligence

Bacterial Pneumonia Market - DataM Intelligence

The Bacterial Pneumonia Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/bacterial-pneumonia-market

What is the projected growth rate (CAGR) of the Global Bacterial Pneumonia market from 2024 to 2031, and what is the market value expected to change by 2031?

The Global Bacterial Pneumonia market reached US$ 2.7 billion in 2022 and is expected to reach US$ 5.0 billion by 2030 growing with a CAGR of 8.1% during the forecast period 2024-2031.

Key Developments:

On July 27, 2023, Merck released encouraging topline findings from two Phase 3 studies assessing V116, the company's experimental 21-valent pneumococcal conjugate Drugs, in those who had never received a Drugs before and those who had. The first pneumococcal conjugate vaccination created especially for adults, if authorized, would be V116. Results from the STRIDE-3 trial showed that in adults who had never received a Drugs, serotype-specific opsonophagocytic activity (OPA) measured 30 days after vaccination revealed significant immune responses in comparison with PCV20 (pneumococcal 20-valent conjugate Drugs).

On June 1, 2023, the Phase 3 program, which included the ASSEMBLE (NCT03580044) and REVISIT (NCT03329092) studies evaluating the effectiveness, safety, and acceptability of the newly developed investigational antibiotic aztreonam-avibactam (ATM-AVI) combination in treating severe bacterial infections caused by Gram-negative bacteria, has produced encouraging results, according to Innoviva Inc. Data show that ATM-AVI is safe, efficacious, well-tolerated, and has an identical safety profile to that of aztreonam alone.

List of the Key Players in the Bacterial Pneumonia Market:

Innoviva Inc., Pfizer Inc., Merck & Co., Inc., Melinta Therapeutics LLC, Evopoint Biosciences, Aridis Pharmaceuticals Inc., Cumberland Pharmaceuticals Inc., Eagle Pharmaceuticals, Inc., Clarametyx Biosciences and Basilea Pharmaceutica Ltd.

Research Process:

Both primary and secondary data sources have been used in the global Bacterial Pneumonia Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Bacterial Pneumonia Market:

By Type (Community-Acquired Pneumonia (CAP), Hospital-Acquired Pneumonia (HAP))

By Route of Administration (Oral, Subcutaneous, Other)

By Treatments (Vaccines, Drugs)

By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Regional Breakout:

The global Bacterial Pneumonia Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

✫ North America (U.S., Canada, Mexico)

✫ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

✫ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

✫ South America (Colombia, Brazil, Argentina, Rest of South America)

✫ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Get Year End Discounts on Premium Report:- https://www.datamintelligence.com/buy-now-page?report=bacterial-pneumonia-market

This Report Unveils:

✔ Go to Market Strategy- A roadmap to successfully product launch or service in the target market.

✔ Gain a clear picture of the market's health and growth trajectory through neutral analysis.

✔ Deep Market Insights delve into development trends, competitor landscape, supply and demand dynamics, brand share & pricing analysis year-over-year growth patterns, and key players' performance.

✔ Upon request, we can provide customized reports focusing on specific regions or countries, offering a granular view of their markets.

✔ Identify high-potential niche segments and regions poised for significant expansion.

✔ Analysis of Market Size (historical and forecast) Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) to understand the market's overall size and your achievable market share.

✔ Gain a comprehensive understanding of the competitive landscape, including market share distribution, key players (innovators, startups, laggards, and pioneers), and their respective strengths and weaknesses.

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Bacterial Pneumonia manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Bacterial Pneumonia in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the Bacterial Pneumonia market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the Bacterial Pneumonia market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/bacterial-pneumonia-market

Frequently Asked Questions

☞ What is the expected growth rate of the global Bacterial Pneumonia market for the forecast period?

☞ What are the key driving factors that are responsible to shape the fate of the Bacterial Pneumonia market during the forecast period?

☞ What will be the overall size of the market during the analysis period?

☞ What are the prominent market trends which influence the development of the Bacterial Pneumonia market across various regions?

☞ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☞ What are the challenges and threats that are likely to act as a barrier to the growth of the Bacterial Pneumonia market?

☞ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bacterial Pneumonia Market: Company Profiles, Segments, and Recent Trends Forecast by 2031 | Melinta Therapeutics LLC, Evopoint Biosciences, Aridis Pharmaceuticals Inc here

News-ID: 3738624 • Views: …

More Releases from DataM Intelligence 4 Market Research LLP

Obesity Therapeutics Market to Reach US$ 63.75 Billion by 2033 at 21.6% CAGR; North America Leads with 41% Share Led by Novo Nordisk and Eli Lilly
Obesity Therapeutics Market to Reach US$ 63.75 Billion by 2033 at 21.6% CAGR; No …
The Global Obesity Therapeutics Market reached US$ 9.19 billion in 2023 and increased to US$ 11.03 billion in 2024, and is expected to reach US$ 63.75 billion by 2033, growing at a CAGR of 21.6% during the forecast period 2025-2033. Market growth is driven by the rising global prevalence of obesity and the rapid adoption of highly effective pharmacological treatments. Obesity therapeutics include lifestyle interventions, pharmacotherapy, and advanced drug treatments, with…
Construction Glass Market is to reach USD 147.3 billion by 2029, Asia Pacific leads the market with 37% market share. Major Players:- Asahi India Glass Limited, Central Glass Co. Ltd., Schott AG
Construction Glass Market is to reach USD 147.3 billion by 2029, Asia Pacific le …
The Construction Glass Market was valued at USD 115.0 billion in 2024 and is projected to reach USD 147.3 billion by 2029, growing at 5.3% cagr from 2024 to 2029. The Low-e glass and special glass types are coated to regulate temperatures and sunlight, significantly reducing energy consumption for heating and cooling buildings. Extensive use of glass allows for ample natural light, which improves aesthetics and potentially reduces reliance on…
Ophthalmology Drugs Market to Reach US$ 73.97 Billion by 2033 at 5.8% CAGR; North America Leads with 38% Share Led by Roche and Novartis
Ophthalmology Drugs Market to Reach US$ 73.97 Billion by 2033 at 5.8% CAGR; Nort …
The Global Ophthalmology Drugs Market reached US$ 42.30 billion in 2023 and increased to US$ 44.58 billion in 2024, and is expected to reach US$ 73.97 billion by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033. Market growth is driven by the rising prevalence of eye disorders such as age-related macular degeneration, glaucoma, diabetic retinopathy, and cataracts, particularly among the aging global population. Ophthalmology drugs are used…
Regenerative Agriculture Market Set for Explosive Growth to USD 48.14 Billion by 2032, Led by North America's Dominant Market Share | DataM Intelligence
Regenerative Agriculture Market Set for Explosive Growth to USD 48.14 Billion by …
The Global Regenerative Agriculture Market reached USD 12,634.54 million in 2024 and is projected to reach USD 48,139.24 million by 2032, growing at a CAGR of 18.20% during the forecast period 2025-2032. Market growth is driven by rising demand for sustainable farming practices, increasing consumer preference for organic and regenerative products, and the need to combat soil degradation and climate change impacts. Advancements in cover cropping, no-till farming, and agroforestry techniques,…

All 5 Releases


More Releases for Pneumonia

Nosocomial pneumonia, which is acquired in hospitals, and pneumonia linked to ve …
Hospital-acquired pneumonia (HAP), also known as nosocomial pneumonia, is a severe lung infection that develops 48 hours or more after hospital admission, often associated with invasive procedures such as mechanical ventilation. It is one of the most common healthcare-associated infections, contributing significantly to morbidity, mortality, and healthcare costs. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72903 With the rise of antibiotic resistance, aging populations, and increased use of ventilators in…
Pneumonia Testing Market: Trends, Opportunities, and Challenges
The global pneumonia testing market is experiencing steady growth, valued at $1.6 billion in 2020 and projected to reach $3.0 billion by 2030, at a CAGR of 6.5% (2021-2030). Pneumonia, a serious respiratory infection, remains a leading cause of morbidity and mortality worldwide. With advancements in diagnostic technologies and increased healthcare awareness, the market for pneumonia testing is expanding rapidly. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3776 Key Market Drivers • Rise…
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To …
How Are the key drivers contributing to the expansion of the pneumonia therapeutics market? The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies like…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills. Read Report Overview -…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview: The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH.  Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market.  Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…